Skip to main content
. 2022 Aug 2;29(9):1093–1100. doi: 10.1097/GME.0000000000002019

FIG. 5.

FIG. 5

Forest plot of the rate of resumed ovarian function with GnRHa plus chemotherapy versus chemotherapy alone in hormone receptor-negative patients. GnRHa, gonadotropin-releasing hormone agonist.